| P2093 | author name string | Eveline Boucher | |
| | Jean-Luc Raoul | |
| | Marine Gilabert | |
| | Etienne Garin | |
| | Julien Edeline | |
| P2860 | cites work | Treatment of unresectable primary and metastatic liver cancer with yttrium-90 microspheres (TheraSphere): assessment of hepatic arterial embolization. | Q51192472 |
| | Radioembolization with yttrium-90 glass microspheres in hepatocellular carcinoma: European experience on safety and long-term survival. | Q51642133 |
| | Dosimetry based on 99mTc-macroaggregated albumin SPECT/CT accurately predicts tumor response and survival in hepatocellular carcinoma patients treated with 90Y-loaded glass microspheres: preliminary results. | Q53671257 |
| | Yttrium-90 radioembolization vs sorafenib for intermediate-locally advanced hepatocellular carcinoma: a cohort study with propensity score analysis | Q56970979 |
| | Yttrium-90 radioembolization for intermediate-advanced hepatocellular carcinoma: A phase 2 study | Q57763422 |
| | Radiation Lobectomy: Preliminary Findings of Hepatic Volumetric Response to Lobar Yttrium-90 Radioembolization | Q63198749 |
| | Radiologic-pathologic correlation of hepatocellular carcinoma treated with internal radiation using yttrium-90 microspheres | Q63198750 |
| | Adjuvant intra-arterial iodine-131-labeled lipiodol for resectable hepatocellular carcinoma: a prospective randomized trial-update on 5-year and 10-year survival | Q80402084 |
| | Adjuvant intraarterial injection of 131I-labeled lipiodol after resection of hepatocellular carcinoma: progress report of a case-control study with a 5-year minimal follow-up | Q80738046 |
| | A retrospective comparative analysis of the effect of Y90-radioembolization on the survival of patients with unresectable hepatocellular carcinoma | Q83158932 |
| | A comparative analysis of transarterial downstaging for hepatocellular carcinoma: chemoembolization versus radioembolization | Q84121312 |
| | Comparative analysis of the safety and efficacy of transcatheter arterial chemoembolization and yttrium-90 radioembolization in patients with unresectable hepatocellular carcinoma | Q85064441 |
| | Volumetric changes after (90)y radioembolization for hepatocellular carcinoma in cirrhosis: an option to portal vein embolization in a preoperative setting? | Q86389913 |
| | Characteristics of primary and secondary hepatic malignancies associated with hepatopulmonary shunting | Q87304965 |
| | Unresectable solitary hepatocellular carcinoma not amenable to radiofrequency ablation: multicenter radiology-pathology correlation and survival of radiation segmentectomy | Q87585663 |
| | Drug therapy for advanced-stage liver cancer | Q27004410 |
| | EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma | Q27860783 |
| | Increased Quality of Life Among Hepatocellular Carcinoma Patients Treated With Radioembolization, Compared With Chemoembolization | Q28111719 |
| | Therapeutic equivalence in survival for hepatic arterial chemoembolization and yttrium 90 microsphere treatments in unresectable hepatocellular carcinoma: a two-cohort study | Q33691454 |
| | Comparison of yttrium-90 radioembolization and transcatheter arterial chemoembolization for the treatment of unresectable hepatocellular carcinoma | Q34089023 |
| | Safety and efficacy of 90Y radiotherapy for hepatocellular carcinoma with and without portal vein thrombosis | Q34585175 |
| | Radiotherapy for hepatocellular carcinoma: systematic review of radiobiology and modeling projections indicate reconsideration of its use. | Q34615726 |
| | Radioembolization with use of yttrium-90 resin microspheres in patients with hepatocellular carcinoma and portal vein thrombosis | Q34621197 |
| | Prospective randomized trial of chemoembolization versus intra-arterial injection of 131I-labeled-iodized oil in the treatment of hepatocellular carcinoma | Q34743529 |
| | Radioembolization for hepatocellular carcinoma using Yttrium-90 microspheres: a comprehensive report of long-term outcomes | Q35004090 |
| | Radioembolization results in longer time-to-progression and reduced toxicity compared with chemoembolization in patients with hepatocellular carcinoma | Q35085486 |
| | Research reporting standards for radioembolization of hepatic malignancies. | Q35111887 |
| | Multicenter phase II study of sequential radioembolization-sorafenib therapy for inoperable hepatocellular carcinoma | Q35116226 |
| | Transarterial radioembolization versus chemoembolization for the treatment of hepatocellular carcinoma (TRACE): study protocol for a randomized controlled trial | Q36383875 |
| | Efficacy and safety of transarterial radioembolization versus chemoembolization in patients with hepatocellular carcinoma. | Q36673829 |
| | Boosted selective internal radiation therapy with 90Y-loaded glass microspheres (B-SIRT) for hepatocellular carcinoma patients: a new personalized promising concept | Q36920698 |
| | Treatment parameters and outcome in 680 treatments of internal radiation with resin 90Y-microspheres for unresectable hepatic tumors | Q37373799 |
| | Radiation lobectomy: time-dependent analysis of future liver remnant volume in unresectable liver cancer as a bridge to resection. | Q37376714 |
| | Radiological-pathological analysis of WHO, RECIST, EASL, mRECIST and DWI: Imaging analysis from a prospective randomized trial of Y90 ± sorafenib | Q37396802 |
| | Complications following radioembolization with yttrium-90 microspheres: a comprehensive literature review. | Q37565869 |
| | Treatment of hepatocellular carcinoma with intra-arterial injection of radionuclides | Q37669167 |
| | Need, feasibility and convenience of dosimetric treatment planning in liver selective internal radiation therapy with (90)Y microspheres: the experience of the National Tumor Institute of Milan | Q37850992 |
| | Yttrium-90 radioembolization as a bridge to liver transplantation: a single-institution experience | Q38155625 |
| | Underlying liver disease influences volumetric changes in the spared hemiliver after selective internal radiation therapy with 90Y in patients with hepatocellular carcinoma | Q38211814 |
| | How to define transarterial chemoembolization failure or refractoriness: a European perspective | Q38221512 |
| | Treatment of intermediate-stage hepatocellular carcinoma | Q38236876 |
| | In intermediate stage hepatocellular carcinoma: radioembolization with yttrium 90 or chemoembolization? | Q38984450 |
| | Left-liver hypertrophy after therapeutic right-liver radioembolization is substantial but less than after portal vein embolization. | Q39310997 |
| | Superselective yttrium-90 radioembolization for hepatocellular carcinoma yields high response rates with minimal toxicity | Q40192043 |
| | Biomarkers and Personalized Sorafenib Therapy | Q41879721 |
| | Choi criteria are superior in evaluating tumor response in patients treated with transarterial radioembolization for hepatocellular carcinoma | Q42002544 |
| | Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma: subanalyses of a phase III trial | Q44089673 |
| | Prospective randomized pilot study of Y90+/-sorafenib as bridge to transplantation in hepatocellular carcinoma. | Q44153080 |
| | Prognostic factors and prevention of radioembolization-induced liver disease | Q45850436 |
| | Use of Yttrium-90 glass microspheres (TheraSphere) for the treatment of unresectable hepatocellular carcinoma in patients with portal vein thrombosis | Q47819721 |
| | Liver disease induced by radioembolization of liver tumors: description and possible risk factors | Q47925759 |
| | Survival after yttrium-90 resin microsphere radioembolization of hepatocellular carcinoma across Barcelona clinic liver cancer stages: a European evaluation. | Q50535030 |
| | Radioembolization With Yttrium-90 Resin Microspheres in Hepatocellular Carcinoma: A Multicenter Prospective Study. | Q50770174 |
| P433 | issue | 1 | |
| P921 | main subject | yttrium | Q941 |
| | microsphere | Q1759020 |
| P304 | page(s) | 16-25 | |
| P577 | publication date | 2015-03-01 | |
| P1433 | published in | Liver cancer | Q26842090 |
| P1476 | title | Yttrium-90 microsphere radioembolization for hepatocellular carcinoma | |
| P478 | volume | 4 | |